141 related articles for article (PubMed ID: 19384118)
1. Factors affecting risk of mortality in women with vaginal cancer.
Shah CA; Goff BA; Lowe K; Peters WA; Li CI
Obstet Gynecol; 2009 May; 113(5):1038-1045. PubMed ID: 19384118
[TBL] [Abstract][Full Text] [Related]
2. Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database.
Ghezelayagh T; Rauh-Hain JA; Growdon WB
Obstet Gynecol; 2015 Jun; 125(6):1353-1361. PubMed ID: 26000506
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of vaginectomy compared to local tumor excision in women with FIGO stage I and II primary vaginal carcinoma: a SEER study.
Zhou W; Yue Y; Pei D
Arch Gynecol Obstet; 2020 Dec; 302(6):1429-1439. PubMed ID: 32780160
[TBL] [Abstract][Full Text] [Related]
4. Disparities in treatment and survival between African American and White women with vaginal cancer.
Mahdi H; Kumar S; Hanna RK; Munkarah AR; Lockhart D; Morris RT; Tamimi H; Swensen RE; Doherty M
Gynecol Oncol; 2011 Jul; 122(1):38-41. PubMed ID: 21497383
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of clinical tumor size on overall survival for subclassifying stages I and II vaginal cancer: A SEER analysis.
Wolfson AH; Reis IM; Portelance L; Diaz DA; Zhao W; Gibb RK
Gynecol Oncol; 2016 May; 141(2):255-259. PubMed ID: 26970567
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
7. Invasive vaginal carcinoma: analysis of early-stage disease.
Davis KP; Stanhope CR; Garton GR; Atkinson EJ; O'Brien PC
Gynecol Oncol; 1991 Aug; 42(2):131-6. PubMed ID: 1894171
[TBL] [Abstract][Full Text] [Related]
8. Treatment approach and outcomes of vaginal melanoma.
Kirschner AN; Kidd EA; Dewees T; Perkins SM
Int J Gynecol Cancer; 2013 Oct; 23(8):1484-9. PubMed ID: 23945202
[TBL] [Abstract][Full Text] [Related]
9. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
10. A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities.
Stock RG; Chen AS; Seski J
Gynecol Oncol; 1995 Jan; 56(1):45-52. PubMed ID: 7821847
[TBL] [Abstract][Full Text] [Related]
11. Management and outcomes of primary vaginal Cancer.
Yang J; Delara R; Magrina J; Magtibay P; Langstraat C; Dinh T; Karlin N; Vora SA; Butler K
Gynecol Oncol; 2020 Nov; 159(2):456-463. PubMed ID: 32972784
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy improves survival in primary vaginal cancer.
Orton A; Boothe D; Williams N; Buchmiller T; Huang YJ; Suneja G; Poppe M; Gaffney D
Gynecol Oncol; 2016 Jun; 141(3):501-506. PubMed ID: 27036631
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic factors and breast carcinoma in multicultural women.
Baquet CR; Commiskey P
Cancer; 2000 Mar; 88(5 Suppl):1256-64. PubMed ID: 10705364
[TBL] [Abstract][Full Text] [Related]
14. Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients.
Wohlmuth C; Wohlmuth-Wieser I; May T; Vicus D; Gien LT; Laframboise S
Am J Clin Dermatol; 2020 Apr; 21(2):285-295. PubMed ID: 31784896
[TBL] [Abstract][Full Text] [Related]
15. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States.
Stroup AM; Harlan LC; Trimble EL
Gynecol Oncol; 2008 Mar; 108(3):577-83. PubMed ID: 18155274
[TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States.
Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG
Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the vagina.
Beller U; Maisonneuve P; Benedet JL; Heintz AP; Ngan HY; Pecorelli S; Odicino F; Creasman WT
Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 1():27-39. PubMed ID: 14763168
[No Abstract] [Full Text] [Related]
18. Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study.
Rajagopalan MS; Xu KM; Lin JF; Sukumvanich P; Krivak TC; Beriwal S
Gynecol Oncol; 2014 Dec; 135(3):495-502. PubMed ID: 25281493
[TBL] [Abstract][Full Text] [Related]
19. Management of Vaginal Cancer.
Shrivastava SB; Agrawal G; Mittal M; Mishra P
Rev Recent Clin Trials; 2015; 10(4):289-97. PubMed ID: 26411952
[TBL] [Abstract][Full Text] [Related]
20. Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark - A nationwide population-based study.
Bertoli HK; Baandrup L; Aalborg GL; Kjaer AK; Thomsen LT; Kjaer SK
Gynecol Oncol; 2020 Sep; 158(3):734-739. PubMed ID: 32571683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
